ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselMyria Biosciences AG
Myria Biosciences AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Myria Biosciences AG develops biopharmaceutical drug candidates using data-driven design and biological production. Its GEMMS platform uses engineered cells to design, produce, test and optimise novel molecules for targeted disease applications.

AI-generated
Presence

Service area

LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.0/5

Myria Biosciences AG

Offering

Products & services

Industry:Pharmaceutical company
✓ Offered3
Discovery of new drug candidates
Discovery of new drug candidates from natural product-inspired molecules, with AI-supported design, biological production and high-throughput analysis for hard-to-address disease targets.
Development of therapeutic molecules with the GEMMS Platform
Design and biological production of therapeutic compounds using Genetically Engineered Modular Molecule Scaffolds to generate, test and optimize millions of new molecules.
AI-assisted microbial engineering for drug development
Use of AI and genetically engineered microbes to generate new, natural product-inspired molecules for medical and pharmaceutical applications.
Trust & reputation

ranQ Trust Score of Myria Biosciences AG: 4.0 out of 5.0

Trust Score4.0/ 5.0

High

x

Data basis 54% · As of November 2026

Myria Biosciences AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Myria Biosciences AG scores 67.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.58.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Myria Biosciences AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Myria Biosciences AG scores 25.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.25.74%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Myria Biosciences AG reaches a ranQ Trust Score of 4.0 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Myria Biosciences AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Myria Biosciences AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Myria Biosciences AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Myria Biosciences AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hochbergerstrasse 60c
4057 Basel
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-386.417.298
Founded
2022 · 4 years
Last commercial register change
May 7, 2024
Employees
1 to 10

Active in 1 of 26 cantons

  • BSBasel-City
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • Full methodology

    Similar companies

    ST
    Skyhawk Therapeutics Europe GmbH
    Basel
    PT
    ProPharma Therapeutics GmbH
    Basel
    MR
    Monte Rosa Therapeutics AG
    Basel
    BA
    BioVersys AG
    Basel
    GG
    Galapagos GmbH
    Basel
    NP
    Nxera Pharma CH Services GmbH
    Basel
    LT
    LifeMine Therapeutics (Switzerland) GmbH
    Basel
    AT
    Aukera Therapeutics AG
    Basel